
Argent Bio’s Stock Flies on German Approval, Jazz Hit by Tariff Barrage, & Kanabo Cautions ‘Financial Uncertainty’
Argent BioPharma Argent BioPharma has managed to overcome the wider chaos on the stock markets this week, seeing its

Argent BioPharma Argent BioPharma has managed to overcome the wider chaos on the stock markets this week, seeing its

Ananda Developments Ananda Developments’ CEO has seemingly forced the hand of one of the UK’s most popular investment service

North American cannabis stocks fly on DEA decision On Tuesday (April 30), news broke via a leak to the press

Last month, London Stock Exchange (LSE) listed digital health operator Kanabo launched a major expansion of its online clinic, which

Germany’s passage of CanG continues to drive up stock prices Yesterday, the President of Bundesrat, Manuela Schwesig, signed Germany’s landmark

Love Hemp The formerly Aquis-listed UK CBD retailer, which collapsed into administration and saw its shares withdrawn in February last

The sixth annual Cannabis Invest UK conference took place in the heart of London last week, bringing together cannabis business,

Akanda Akanda has seen its stock rise by around 7% this week as it rode the wave of positive

Kanabo Group plc (LSE: KNB), the patient-focused provider of digital health services and specialist medicines, including medicinal cannabis, is pleased

Kanabo Group plc (LSE: KNB), the patient-focused provider of digital health services and specialist medicines, including medicinal cannabis, is pleased
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.